DGX - Quest Diagnostics Incorporated
NYSE - NYSE Delayed Price. Currency in USD
Currency in USD
Valuation measures4
| Market cap (intra-day) | 15.55B |
| Enterprise value | 19.99B |
| Trailing P/E | 20.32 |
| Forward P/E | 15.97 |
| PEG Ratio (5 yr expected) | 3.30 |
| Price/sales (ttm) | 1.68 |
| Price/book (mrq) | 2.57 |
| Enterprise value/revenue | 2.02 |
| Enterprise value/EBITDA | 10.99 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.94 |
| 52-week change 3 | -3.42% |
| S&P500 52-week change 3 | 2.54% |
| 52-week high 3 | 158.34 |
| 52-week low 3 | 120.40 |
| 50-day moving average 3 | 137.99 |
| 200-day moving average 3 | 139.67 |
Share statistics
| Avg vol (3-month) 3 | 1.11M |
| Avg vol (10-day) 3 | 904.27k |
| Shares outstanding 5 | 112.01M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 111.01M |
| % held by insiders 1 | 0.83% |
| % held by institutions 1 | 92.97% |
| Shares short (14 May 2023) 4 | 4.08M |
| Short ratio (14 May 2023) 4 | 3.78 |
| Short % of float (14 May 2023) 4 | 4.78% |
| Short % of shares outstanding (14 May 2023) 4 | 3.64% |
| Shares short (prior month 13 Apr 2023) 4 | 4.12M |
Dividends & splits
| Forward annual dividend rate 4 | 2.84 |
| Forward annual dividend yield 4 | 2.12% |
| Trailing annual dividend rate 3 | 2.69 |
| Trailing annual dividend yield 3 | 2.01% |
| 5-year average dividend yield 4 | 1.90 |
| Payout ratio 4 | 39.39% |
| Dividend date 3 | 24 Jul 2023 |
| Ex-dividend date 4 | 09 Jul 2023 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 20 Jun 2005 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Mar 2023 |
Profitability
| Profit margin | 8.26% |
| Operating margin (ttm) | 14.07% |
Management effectiveness
| Return on assets (ttm) | 6.44% |
| Return on equity (ttm) | 13.57% |
Income statement
| Revenue (ttm) | 9.6B |
| Revenue per share (ttm) | 84.05 |
| Quarterly revenue growth (yoy) | -10.70% |
| Gross profit (ttm) | 3.47B |
| EBITDA | 1.79B |
| Net income avi to common (ttm) | 789M |
| Diluted EPS (ttm) | 6.83 |
| Quarterly earnings growth (yoy) | -43.10% |
Balance sheet
| Total cash (mrq) | 175M |
| Total cash per share (mrq) | 1.56 |
| Total debt (mrq) | 4.62B |
| Total debt/equity (mrq) | 74.97 |
| Current ratio (mrq) | 1.34 |
| Book value per share (mrq) | 54.02 |
Cash flow statement
| Operating cash flow (ttm) | 1.33B |
| Levered free cash flow (ttm) | 554.88M |
© 2023 Yahoo. All rights reserved.